Wendy Sue Yeropoli LPC

Recommended Articles

• Questions You Should Be Asking Your Doctor

  IntroductionAlthough doctors have the best intentions, it does not always mean that they will perfectly recognize their patient’s greatest need. For this reason, patients also need to take an active role when it comes to communicating with their doctor.One of the best ways to make sure that...

• Why Children Should Avoid Energy Drinks

  The American Academy of Pediatrics clearly mentions that children should not drink high-octane energy drinks and should avoid having sports drinks. Energy drinks are unhealthy because of the high content of caffeine and other stimulants present in the drink, according to a report published in,...

• It’s Never Too Late: Woman Lost 250 Pounds After Diagnosed with Sleep Apnea and Diabetes

  Clocking at over 405 pounds, Elle Goodall needed to change her habits. After being diagnosed with diabetes mellitus at age 26, doctors warned her that she would not live past her 40s due to obesity. Instead of slumping into depression, she decided to make herself feel better.Changing Her Diet Plan...

• How Does Alcohol Impact Rheumatoid Arthritis?

  The impact of alcohol on health is widely debated, and now many want to know how these questions are altered in regards to rheumatoid arthritis.Is drinking with RA a problem?We've all heard from a young age that everything in moderation is fine - even drinking. Some even go as far to say that it can...

• Study Reveals Lack of Follow-Up Treatment for Celiac Patients

  Celiac disease is a lifelong condition that can radically alter someone's way of life, prompting him or her to switch to different eating habits, adopting a more active lifestyle, and adopting healthier measures, in general. Those who are struggling with the disease must make regular visits to their...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...